Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.

Stopped GSK has elected to terminate development principally as a result of the statin drug-drug interaction (DDI) study.

Conditions

• Colitis, Ulcerative

Interventions

• DRUG: GSK2586184 400mg

Sponsor

GlaxoSmithKline

Collaborators

• [object Object]